抗生素
抗药性
药品
抗生素耐药性
药物输送
医学
重症监护医学
计算机科学
药理学
微生物学
生物
纳米技术
材料科学
作者
Sumit Durgapal,B. C. Joshi,Bhanu Pandey,Gauree Kukreti,Archana Dhyani,Akash Jain,Sayantan Mukhopadhyay,Minky Mukhija,Prabhjot Singh Bajwa
出处
期刊:Advances in medical diagnosis, treatment, and care (AMDTC) book series
日期:2024-03-15
卷期号:: 1-32
标识
DOI:10.4018/979-8-3693-4139-1.ch001
摘要
The global emergence of antibacterial resistance poses a severe threat to human life, echoing Alexander Fleming's cautionary prediction about the misuse of antibiotics. In the current era, many existing antibacterials are increasingly losing effectiveness against various microorganisms. Overuse and suboptimal exposure provide fertile ground for microbial thriving and the development of resistance through mechanisms like cell membrane protection, target modification, enzymatic inactivation, and drug efflux. Conventional drug delivery systems struggle against this evolving bacterial resistance. Consequently, there's a pressing need for innovative strategies to combat antibacterial drug resistance. Nanotechnology-based targeted drug delivery systems offer a promising solution. These systems enhance drug solubility, permeability, bioavailability, stability, and efficacy while minimizing toxicity. This chapter explores the concept of targeted drug delivery to address antibacterial resistance, focusing on mechanisms, approaches, and recent advancements.
科研通智能强力驱动
Strongly Powered by AbleSci AI